$KBDC
Kayne Anderson BDC Inc Stock $kbdc

$kbdc Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023067086 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$21.37M	$21.73M	$7.140M
YoY Change	90.22%	204.38%
Cost Of Revenue	$19.15M
YoY Change
Gross Profit	$22.05M
YoY Change
Gross Profit Margin	103.19%
Selling, General & Admin	$681.0K
YoY Change
% of Gross Profit	3.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$19.83M	$19.01M	$5.851M
YoY Change	114.13%	224.95%
Operating Profit	$2.222M	-$19.01M
YoY Change
Interest Expense	$13.87M	$13.00M	$3.014M
YoY Change	152.02%	331.39%
% of Operating Profit	624.26%
Other Income/Expense, Net
YoY Change
Pretax Income	$13.87M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	$13.87M	$21.00M
YoY Change
Net Earnings / Revenue	64.92%	96.64%
Basic Earnings Per Share	$0.53	$0.56	$0.30
Diluted Earnings Per Share	$0.53	$0.56	$0.30
COMMON SHARES
Basic Shares Outstanding	41.51M shares	39.01M shares	23.53M shares
Diluted Shares Outstanding	40.50M shares	38.91M shares	23.53M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.38M
YoY Change
Cash & Equivalents	$12.38M	$12.92M	$3.414M
Short-Term Investments
Other Short-Term Assets	$119.0K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$12.68M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.294B
YoY Change	25138.51%
Other Assets
YoY Change
Total Long-Term Assets	$1.308B
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$12.68M
Total Long-Term Assets	$1.308B
Total Assets	$1.321B	$1.325B
YoY Change	33.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$10.60M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$47.19M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$598.0M
YoY Change
Other Long-Term Liabilities	-$5.289M
YoY Change
Total Long-Term Liabilities	$592.7M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$47.19M
Total Long-Term Liabilities	$592.7M
Total Liabilities	$639.9M	$677.7M
YoY Change	36.52%
SHAREHOLDERS EQUITY
Retained Earnings	$12.18M	$20.31M
YoY Change	-52.88%
Common Stock	$668.5M	$39.00K
YoY Change	2156503.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$680.7M	$646.9M	$389.8M
YoY Change
Total Liabilities & Shareholders Equity	$1.321B	$1.325B
YoY Change	33.07%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	$13.87M	$21.00M
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$56.30M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	60.16M
YoY Change
NET CHANGE
Cash From Operating Activities	-56.30M
Cash From Investing Activities
Cash From Financing Activities	60.16M
Net Change In Cash	3.858M
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$56.30M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	814-01363
	dei	Entity Registrant Name EntityRegistrantName	Kayne Anderson BDC, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-0531326
	dei	Entity Address Address Line1 EntityAddressAddressLine1	811 Main Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	14th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77002
	dei	City Area Code CityAreaCode	(713)
	dei	Local Phone Number LocalPhoneNumber	493-2020
	dei	Security12b Title Security12bTitle	None
	dei	Trading Symbol TradingSymbol	None
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41506935	shares
CY2023Q2	ck0001747172	Longterm Investmentsamortized Cost LongtermInvestmentsamortizedCost	1267227000	usd
CY2022Q4	ck0001747172	Longterm Investmentsamortized Cost LongtermInvestmentsamortizedCost	1147788000	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	1283951000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	1165119000	usd
CY2023Q2	ck0001747172	Shortterm Investmentsamortized Cost ShorttermInvestmentsamortizedCost	15094000	usd
CY2022Q4	ck0001747172	Shortterm Investmentsamortized Cost ShorttermInvestmentsamortizedCost	9847000	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	15094000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	9847000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12919000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8526000	usd
CY2023Q2	ck0001747172	Receivable For Principal Payments On Investments ReceivableForPrincipalPaymentsOnInvestments	148000	usd
CY2022Q4	ck0001747172	Receivable For Principal Payments On Investments ReceivableForPrincipalPaymentsOnInvestments	111000	usd
CY2023Q2	us-gaap	Interest Receivable InterestReceivable	12270000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	10444000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	207000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	347000	usd
CY2023Q2	us-gaap	Assets Assets	1324589000	usd
CY2022Q4	us-gaap	Assets Assets	1194394000	usd
CY2023Q2	us-gaap	Line Of Credit LineOfCredit	237000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	269000000	usd
CY2023Q2	ck0001747172	Unamortized Corporate Credit Facility Issuance Costs UnamortizedCorporateCreditFacilityIssuanceCosts	-2120000	usd
CY2022Q4	ck0001747172	Unamortized Corporate Credit Facility Issuance Costs UnamortizedCorporateCreditFacilityIssuanceCosts	-2517000	usd
CY2023Q2	ck0001747172	Revolving Funding Facility Note RevolvingFundingFacilityNote	320000000	usd
CY2022Q4	ck0001747172	Revolving Funding Facility Note RevolvingFundingFacilityNote	200000000	usd
CY2023Q2	ck0001747172	Unamortized Revolving Funding Facility Issuance Costs UnamortizedRevolvingFundingFacilityIssuanceCosts	-2850000	usd
CY2022Q4	ck0001747172	Unamortized Revolving Funding Facility Issuance Costs UnamortizedRevolvingFundingFacilityIssuanceCosts	-2827000	usd
CY2023Q2	ck0001747172	Subscription Credit Agreement SubscriptionCreditAgreement	9000000	usd
CY2022Q4	ck0001747172	Subscription Credit Agreement SubscriptionCreditAgreement	108000000	usd
CY2023Q2	ck0001747172	Unamortized Subscription Credit Facility Issuance Costs UnamortizedSubscriptionCreditFacilityIssuanceCosts	-63000	usd
CY2022Q4	ck0001747172	Unamortized Subscription Credit Facility Issuance Costs UnamortizedSubscriptionCreditFacilityIssuanceCosts	-65000	usd
CY2023Q2	ck0001747172	Senior Unsecured Notes SeniorUnsecuredNotes	75000000	usd
CY2023Q2	ck0001747172	Unamortized Notes Issuance Costs UnamortizedNotesIssuanceCosts	-881000	usd
CY2022Q4	ck0001747172	Payable For Investments Purchased PayableForInvestmentsPurchased	956000	usd
CY2023Q2	us-gaap	Distribution Payable DistributionPayable	20678000	usd
CY2022Q4	us-gaap	Distribution Payable DistributionPayable	15428000	usd
CY2023Q2	us-gaap	Management Fee Payable ManagementFeePayable	2848000	usd
CY2022Q4	us-gaap	Management Fee Payable ManagementFeePayable	2415000	usd
CY2023Q2	us-gaap	Incentive Fee Payable IncentiveFeePayable	9320000	usd
CY2022Q4	us-gaap	Incentive Fee Payable IncentiveFeePayable	4762000	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	9731000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	7201000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	677663000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	602353000	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39013826	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39013826	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35879291	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35879291	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	39000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	36000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	626581000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	574540000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	20306000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	17465000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	646926000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	592041000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1324589000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1194394000	usd
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.58
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.5
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	40746000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	12991000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	77112000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	24892000	usd
CY2023Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	40746000	usd
CY2022Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	12991000	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	77112000	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	24892000	usd
CY2023Q2	us-gaap	Management Fee Expense ManagementFeeExpense	2848000	usd
CY2022Q2	us-gaap	Management Fee Expense ManagementFeeExpense	1498000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	5533000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	2824000	usd
CY2023Q2	us-gaap	Incentive Fee Expense IncentiveFeeExpense	2420000	usd
CY2022Q2	us-gaap	Incentive Fee Expense IncentiveFeeExpense	775000	usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense	4558000	usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense	1730000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	13002000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	3014000	usd
	us-gaap	Interest Expense InterestExpense	24525000	usd
	us-gaap	Interest Expense InterestExpense	5822000	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	143000	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	155000	usd
	us-gaap	Professional Fees ProfessionalFees	293000	usd
	us-gaap	Professional Fees ProfessionalFees	300000	usd
CY2023Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	178000	usd
CY2022Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	107000	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	317000	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	214000	usd
	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost	29000	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	422000	usd
CY2022Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	302000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	871000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	615000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	19013000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	5851000	usd
	us-gaap	Operating Expenses OperatingExpenses	36097000	usd
	us-gaap	Operating Expenses OperatingExpenses	11534000	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	21733000	usd
CY2022Q2	us-gaap	Net Investment Income NetInvestmentIncome	7140000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	41015000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	13358000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	23000	usd
	ck0001747172	Realized Investment Gains Losses Net RealizedInvestmentGainsLossesNet	23000	usd
CY2023Q2	ck0001747172	Net Change In Unrealized Gains Losses Investments NetChangeInUnrealizedGainsLossesInvestments	-731000	usd
CY2022Q2	ck0001747172	Net Change In Unrealized Gains Losses Investments NetChangeInUnrealizedGainsLossesInvestments	322000	usd
	ck0001747172	Net Change In Unrealized Gains Losses Investments NetChangeInUnrealizedGainsLossesInvestments	-606000	usd
	ck0001747172	Net Change In Unrealized Gains Losses Investments NetChangeInUnrealizedGainsLossesInvestments	-190000	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-731000	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	322000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-606000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-190000	usd
CY2023Q2	ck0001747172	Net Realized And Unrealized Gainloss On Investment NetRealizedAndUnrealizedGainlossOnInvestment	-731000	usd
CY2022Q2	ck0001747172	Net Realized And Unrealized Gainloss On Investment NetRealizedAndUnrealizedGainlossOnInvestment	322000	usd
	ck0001747172	Net Realized And Unrealized Gainloss On Investment NetRealizedAndUnrealizedGainlossOnInvestment	-606000	usd
	ck0001747172	Net Realized And Unrealized Gainloss On Investment NetRealizedAndUnrealizedGainlossOnInvestment	-167000	usd
CY2023Q2	ck0001747172	Investment Company Net Asset From Operations Increase Decrease InvestmentCompanyNetAssetFromOperationsIncreaseDecrease	21002000	usd
CY2022Q2	ck0001747172	Investment Company Net Asset From Operations Increase Decrease InvestmentCompanyNetAssetFromOperationsIncreaseDecrease	7462000	usd
	ck0001747172	Investment Company Net Asset From Operations Increase Decrease InvestmentCompanyNetAssetFromOperationsIncreaseDecrease	40409000	usd
	ck0001747172	Investment Company Net Asset From Operations Increase Decrease InvestmentCompanyNetAssetFromOperationsIncreaseDecrease	13191000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.3
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.1
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.54
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.32
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.08
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.57
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38905173	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23529376	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37425525	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22964415	shares
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	21733000	usd
CY2022Q2	us-gaap	Net Investment Income NetInvestmentIncome	7140000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	41015000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	13358000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	23000	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-731000	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	322000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-606000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-190000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	21002000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	7462000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	40409000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	13191000	usd
CY2023Q2	ck0001747172	Investment Company Distribution To Shareholders InvestmentCompanyDistributionToShareholders	20678000	usd
CY2022Q2	ck0001747172	Investment Company Distribution To Shareholders InvestmentCompanyDistributionToShareholders	6103000	usd
	ck0001747172	Investment Company Distribution To Shareholders InvestmentCompanyDistributionToShareholders	37568000	usd
	ck0001747172	Investment Company Distribution To Shareholders InvestmentCompanyDistributionToShareholders	6103000	usd
CY2023Q2	ck0001747172	Net Decrease In Net Assets Resulting From Stockholder Distributions NetDecreaseInNetAssetsResultingFromStockholderDistributions	-20678000	usd
CY2022Q2	ck0001747172	Net Decrease In Net Assets Resulting From Stockholder Distributions NetDecreaseInNetAssetsResultingFromStockholderDistributions	-6103000	usd
	ck0001747172	Net Decrease In Net Assets Resulting From Stockholder Distributions NetDecreaseInNetAssetsResultingFromStockholderDistributions	-37568000	usd
	ck0001747172	Net Decrease In Net Assets Resulting From Stockholder Distributions NetDecreaseInNetAssetsResultingFromStockholderDistributions	-6103000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	68582000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1089000	usd
	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.015	pure
CY2022Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1222000	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	2044000	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	2124000	usd
CY2023Q2	ck0001747172	Net Increase In Net Assets Resulting From Capital Share Transactions NetIncreaseInNetAssetsResultingFromCapitalShareTransactions	51089000	usd
CY2022Q2	ck0001747172	Net Increase In Net Assets Resulting From Capital Share Transactions NetIncreaseInNetAssetsResultingFromCapitalShareTransactions	1222000	usd
	ck0001747172	Net Increase In Net Assets Resulting From Capital Share Transactions NetIncreaseInNetAssetsResultingFromCapitalShareTransactions	52044000	usd
	ck0001747172	Net Increase In Net Assets Resulting From Capital Share Transactions NetIncreaseInNetAssetsResultingFromCapitalShareTransactions	70706000	usd
CY2023Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	51413000	usd
CY2022Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	2581000	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	54885000	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	77794000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	595513000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	387182000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	592041000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	311969000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	646926000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	389763000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	646926000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	389763000	usd
	us-gaap	Profit Loss ProfitLoss	40409000	usd
	us-gaap	Profit Loss ProfitLoss	13191000	usd
	ck0001747172	Net Realizedgainslosses On Investments NetRealizedgainslossesOnInvestments	23000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-606000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-190000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	4317000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	2011000	usd
	ck0001747172	Purchases Of Shortterm Investments Net PurchasesOfShorttermInvestmentsNet	-5247000	usd
	ck0001747172	Purchases Of Shortterm Investments Net PurchasesOfShorttermInvestmentsNet	-4731000	usd
	ck0001747172	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	177629000	usd
	ck0001747172	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	181452000	usd
	ck0001747172	Proceeds From Sales Of Investments And Principal Repayments ProceedsFromSalesOfInvestmentsAndPrincipalRepayments	63543000	usd
	ck0001747172	Proceeds From Sales Of Investments And Principal Repayments ProceedsFromSalesOfInvestmentsAndPrincipalRepayments	43777000	usd
	ck0001747172	Paidinkind Interest From Portfolio Investments PaidinkindInterestFromPortfolioInvestments	1035000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1184000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1005000	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	1826000	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	2217000	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-29000	usd
	ck0001747172	Increasedecrease In Receivable For Principal Payments On Investments IncreasedecreaseInReceivableForPrincipalPaymentsOnInvestments	37000	usd
	ck0001747172	Increasedecrease In Receivable For Principal Payments On Investments IncreasedecreaseInReceivableForPrincipalPaymentsOnInvestments	333000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-140000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	97000	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	-956000	usd
	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	433000	usd
	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	546000	usd
	us-gaap	Increase Decrease In Incentive Fee Payable IncreaseDecreaseInIncentiveFeePayable	4558000	usd
	us-gaap	Increase Decrease In Incentive Fee Payable IncreaseDecreaseInIncentiveFeePayable	1730000	usd
	ck0001747172	Increasedecrease In Accrued Organizational And Offering Costs Net IncreasedecreaseInAccruedOrganizationalAndOfferingCostsNet	-6000	usd
	ck0001747172	Increasedecrease In Accrued Other General And Administrative Expenses IncreasedecreaseInAccruedOtherGeneralAndAdministrativeExpenses	2530000	usd
	ck0001747172	Increasedecrease In Accrued Other General And Administrative Expenses IncreasedecreaseInAccruedOtherGeneralAndAdministrativeExpenses	1978000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-77644000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-128424000	usd
	ck0001747172	Borrowingspayments On Corporate Credit Facility Net BorrowingspaymentsOnCorporateCreditFacilityNet	32000000	usd
	ck0001747172	Borrowingspayments On Corporate Credit Facility Net BorrowingspaymentsOnCorporateCreditFacilityNet	-78000000	usd
	ck0001747172	Borrowings On Revolving Funding Facility Net BorrowingsOnRevolvingFundingFacilityNet	120000000	usd
	ck0001747172	Borrowings On Revolving Funding Facility Net BorrowingsOnRevolvingFundingFacilityNet	150000000	usd
	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-162000000	usd
	ck0001747172	Borrowings On Subscription And Credit Agreement Net BorrowingsOnSubscriptionAndCreditAgreementNet	-99000000	usd
	ck0001747172	Borrowings On Subscription And Credit Agreement Net BorrowingsOnSubscriptionAndCreditAgreementNet	9000000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1689000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5185000	usd
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	30274000	usd
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	8594000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	68582000	usd
	ck0001747172	Proceeds From Issuance Of Notes ProceedsFromIssuanceOfNotes	75000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	82037000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	129803000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	4393000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1379000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8526000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2035000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12919000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3414000	usd
	us-gaap	Interest Paid Net InterestPaidNet	20556000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4654000	usd
	ck0001747172	Noncash Financing Activities Not Included Herein Consisted Of Reinvestment Of Dividends NoncashFinancingActivitiesNotIncludedHereinConsistedOfReinvestmentOfDividends	2044000	usd
	ck0001747172	Noncash Financing Activities Not Included Herein Consisted Of Reinvestment Of Dividends NoncashFinancingActivitiesNotIncludedHereinConsistedOfReinvestmentOfDividends	2124000	usd
CY2023Q2	us-gaap	Investment Company Financial Commitment To Investee Future Amount InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	875188000	usd
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss		usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">C.<i> Use of Estimates</i>—the preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of income and expenses during the period. Actual results could differ materially from those estimates.</p>
	ck0001747172	Third Party Valuation Percentage ThirdPartyValuationPercentage	0.25	pure
	us-gaap	Dividends Paidinkind DividendsPaidinkind	1035000	usd
	ck0001747172	Aggregate Interest Income AggregateInterestIncome	0.013	pure
	ck0001747172	Distributions Percentage DistributionsPercentage	0.90	pure
	us-gaap	Quarterly Financial Information Income Taxes Significant Variation Description QuarterlyFinancialInformationIncomeTaxesSignificantVariationDescription	All RICs are subject to a non-deductible 4% excise tax on income that is not distributed on a timely basis in accordance with the calendar year distribution requirements. To avoid the tax, the Company must distribute during each calendar year an amount at least equal to the sum of (i) 98% of its ordinary income for the calendar year, (ii) 98.2% of its net capital gains for the one-year period ending on December 31, the last day of our taxable year, and (iii) undistributed amounts from previous years on which the Company paid no U.S. federal income tax.
	ck0001747172	Base Management Fee Annual Rate BaseManagementFeeAnnualRate	0.015	pure
	ck0001747172	Fair Market Value In Percentage FairMarketValueInPercentage	0.01	pure
CY2023Q2	us-gaap	Management Fee Expense ManagementFeeExpense	2848000	usd
CY2022Q2	us-gaap	Management Fee Expense ManagementFeeExpense	1498000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	5533000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	2824000	usd
	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.015	pure
	us-gaap	Investment Company Total Return After Incentive Fees InvestmentCompanyTotalReturnAfterIncentiveFees	0.06	pure
	us-gaap	Incentive Fee Description IncentiveFeeDescription	●Prior to an Exchange Listing: 100% of our pre-incentive fee net investment income for the immediately preceding calendar quarter in excess of 1.50% of the Company’s NAV at the end of the immediately preceding calendar quarter until the Advisor has received 10% of the total pre-incentive fee net income for that calendar quarter and, for pre-incentive fee net investment income in excess of 1.6667%, 10% of all remaining pre-incentive fee net investment income for that quarter. ● After an Exchange Listing: 100% of the Company’s pre-incentive fee net investment income for the immediately preceding calendar quarter in excess of 1.50% of the Company’s NAV at the end of the immediately preceding calendar quarter until the Advisor has received 15% of the total pre-incentive fee net income for that calendar quarter and, for pre-incentive fee net investment income in excess of 1.7647%, 15% of all remaining pre-incentive fee net investment income for that quarter.
CY2022Q2	us-gaap	Incentive Fee Expense IncentiveFeeExpense	775000	usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense	4558000	usd
	ck0001747172	Incentive Fee Expense Excluding Capital Gains IncentiveFeeExpenseExcludingCapitalGains	1728000	usd
	ck0001747172	Capital Gains CapitalGains	2000	usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense	1730000	usd
CY2018Q4	us-gaap	Contribution Of Property ContributionOfProperty	10000	usd
CY2023Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1282321000	usd
CY2023Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1299045000	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1157635000	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1174966000	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	70791000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	45901000	usd
CY2023Q2	ck0001747172	Longterm Investments Fair Value Percentage LongtermInvestmentsFairValuePercentage	1	pure
CY2022Q4	ck0001747172	Longterm Investments Fair Value Percentage LongtermInvestmentsFairValuePercentage	1	pure
CY2023Q2	us-gaap	Investments Investments	1276048000	usd
CY2023Q2	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	7903000	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	15094000	usd
CY2023Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	1299045000	usd
CY2022Q4	us-gaap	Investments Investments	1157971000	usd
CY2022Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	7148000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	9847000	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	1174966000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1254359000	usd
	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.01	pure
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	74419000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-46298000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-731000	usd
CY2023Q2	ck0001747172	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Net Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisNetAccretionOfDiscountOnInvestments	2202000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1283951000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	617067000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	114928000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-15615000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	322000	usd
CY2022Q2	ck0001747172	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Net Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisNetAccretionOfDiscountOnInvestments	1262000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	717964000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1165119000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	178664000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-63543000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-606000	usd
	ck0001747172	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Net Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisNetAccretionOfDiscountOnInvestments	4317000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1283951000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	578445000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	181452000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-43777000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-190000	usd
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	23000	usd
	ck0001747172	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Net Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisNetAccretionOfDiscountOnInvestments	2011000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	717964000	usd
CY2023Q2	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	125000000	usd
	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0025	pure
	ck0001747172	Extension Fee ExtensionFee	0.0005	pure
	ck0001747172	Debt Total Commitment DebtTotalCommitment	400000000	usd
CY2023Q2	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0706	pure
CY2022Q2	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0291	pure
	us-gaap	Long Term Debt Average Amount Outstanding LongTermDebtAverageAmountOutstanding	237000000	usd
CY2023Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0275	pure
CY2022Q1	us-gaap	Other Loans Payable OtherLoansPayable	150000000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	75000000	usd
CY2023Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	881000	usd
CY2023Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	75000000	usd
CY2023Q2	ck0001747172	Debt Weighted Average Interest Rate1 DebtWeightedAverageInterestRate1	0.0871	pure
CY2023Q2	ck0001747172	Aggregate Interest Threshold AggregateInterestThreshold	0.02	pure
CY2023Q2	ck0001747172	Asset Coverage Ratio AssetCoverageRatio	1.50	pure
	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	1055000000	usd
	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	641000000	usd
CY2023Q2	ck0001747172	Line Of Credit Available Amount LineOfCreditAvailableAmount	295394000	usd
CY2023Q2	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	635086000	usd
CY2022	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	875000000	usd
CY2022	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	577000000	usd
CY2022Q4	ck0001747172	Line Of Credit Available Amount LineOfCreditAvailableAmount	169793000	usd
CY2022Q4	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	571591000	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	12409000	usd
CY2022Q2	us-gaap	Interest Expense Other InterestExpenseOther	2528000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	593000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	486000	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	13002000	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3014000	usd
CY2023Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.081	pure
CY2022Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.043	pure
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	643780000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	283637000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	23341000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	4817000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1184000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1005000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	24525000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	5822000	usd
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.079	pure
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.045	pure
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	629398000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	262751000	usd
	ck0001747172	Weightedaverage Shares Outstandingin Shares WeightedaverageSharesOutstandinginShares	22964415	shares
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.066	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.036	pure
	us-gaap	Investment Company Portfolio Turnover InvestmentCompanyPortfolioTurnover	0.051	pure
	us-gaap	Investment Company Portfolio Turnover InvestmentCompanyPortfolioTurnover	0.069	pure
	ck0001747172	Ratio Of Operating Expenses To Average Net Assets RatioOfOperatingExpensesToAverageNetAssets	0.119	pure
CY2023Q2	us-gaap	Shares Issued SharesIssued	3010942	shares
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000000	usd
CY2022Q2	us-gaap	Shares Issued SharesIssued	4191292	shares
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	68582000	usd
	ck0001747172	Aggregate Capital Commitment AggregateCapitalCommitment	875188000	usd
CY2023Q2	us-gaap	Other Commitment OtherCommitment	257469000	usd
CY2023Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	1
CY2022Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.26
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	123593	shares
	ck0001747172	Stock Issued During Period Value Dividends Reinvestment Plan StockIssuedDuringPeriodValueDividendsReinvestmentPlan	2044000	usd
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	130860	shares
	ck0001747172	Stock Issued During Period Value Dividends Reinvestment Plan StockIssuedDuringPeriodValueDividendsReinvestmentPlan	2124000	usd
CY2023Q2	ck0001747172	Unfunded Commitments UnfundedCommitments	116145000	usd
CY2022Q4	ck0001747172	Unfunded Commitments UnfundedCommitments	149338000	usd
CY2023Q2	ck0001747172	Unfunded Commitments UnfundedCommitments	116145000	usd
CY2022Q4	ck0001747172	Unfunded Commitments UnfundedCommitments	149338000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	21002000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	7462000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	40409000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	13191000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38905173	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23529376	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37425525	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22964415	shares
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.54
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.32
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.08
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.57
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.5
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.22
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.1
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.58
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.02
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.01
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	1.08
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	0.59
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.26
	ck0001747172	Net Decrease In Net Assets Resulting From Distributions Subtotal NetDecreaseInNetAssetsResultingFromDistributionsSubtotal	-1
	ck0001747172	Net Decrease In Net Assets Resulting From Distributions Subtotal NetDecreaseInNetAssetsResultingFromDistributionsSubtotal	-0.26
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.58
CY2022Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.55
CY2023Q2	us-gaap	Shares Outstanding SharesOutstanding	39013826	shares
CY2022Q2	us-gaap	Shares Outstanding SharesOutstanding	23550054	shares
CY2023Q2	us-gaap	Net Regulatory Assets NetRegulatoryAssets	646926000	usd
CY2022Q2	us-gaap	Net Regulatory Assets NetRegulatoryAssets	389763000	usd
	ck0001747172	Weightedaverage Shares Outstandingin Shares WeightedaverageSharesOutstandinginShares	37425525	shares
	ck0001747172	Ratio Of Operating Expenses To Average Net Assets RatioOfOperatingExpensesToAverageNetAssets	0.064	pure
	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.135	pure
	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.074	pure
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0
CY2022Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.01
CY2022Q2	ck0001747172	Realized Investment Gains Losses Net RealizedInvestmentGainsLossesNet		usd
	ck0001747172	Realized Investment Gains Losses Net RealizedInvestmentGainsLossesNet		usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
	ck0001747172	Net Realizedgainslosses On Investments NetRealizedgainslossesOnInvestments		usd
	ck0001747172	Paidinkind Interest From Portfolio Investments PaidinkindInterestFromPortfolioInvestments		usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges		usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased		usd
	ck0001747172	Increasedecrease In Accrued Organizational And Offering Costs Net IncreasedecreaseInAccruedOrganizationalAndOfferingCostsNet		usd
	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt		usd
	ck0001747172	Proceeds From Issuance Of Notes ProceedsFromIssuanceOfNotes		usd
	us-gaap	Dividends Paidinkind DividendsPaidinkind		usd
CY2023Q2	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss		usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3		usd
CY2022Q2	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss		usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22964415	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23529376	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37425525	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38905173	shares
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.32
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.54
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.57
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.08
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001747172

Files In Submission

Name	View Source	Status
0001213900-23-067086-index-headers.html	Edgar Link	pending
0001213900-23-067086-index.html	Edgar Link	pending
0001213900-23-067086.txt	Edgar Link	pending
0001213900-23-067086-xbrl.zip	Edgar Link	pending
ck0001747172-20230630.xsd	Edgar Link	pending
f10q0623ex31-1_kayneand.htm	Edgar Link	pending
f10q0623ex31-2_kayneand.htm	Edgar Link	pending
f10q0623ex32-1_kayneand.htm	Edgar Link	pending
f10q0623ex32-2_kayneand.htm	Edgar Link	pending
f10q0623_kayneand.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
ck0001747172-20230630_def.xml	Edgar Link	unprocessable
ck0001747172-20230630_cal.xml	Edgar Link	unprocessable
ck0001747172-20230630_pre.xml	Edgar Link	unprocessable
ck0001747172-20230630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0623_kayneand_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KBDC
Kayne Anderson BDC Inc Stock $kbdc

2023 Q3 Form 10-Q Financial Statement

#000121390023067086 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KBDC Kayne Anderson BDC Inc Stock $kbdc

2023 Q3 Form 10-Q Financial Statement

#000121390023067086 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KBDC
Kayne Anderson BDC Inc Stock $kbdc